. | (1) . | (2) . |
---|---|---|
Panel A: Insulin usage 2000 vs. 2006 . | . | |
IMSS |$\times$| 2006 | 0.009 | 0.009 |
p-value | |${(0.709)}$| | |${(0.739)}$| |
95% CI | |$[ -0.16, 0.03]$| | |$[ -0.14, 0.04]$| |
Base controls | X | X |
Health controls | X | |
Observations | 4,145 | 4,145 |
(3) | (4) | |
Panel B: Other treatment | ||
DiD coeff. | |$-0.004$| | |$-0.004$| |
p-value | |${(0.898)}$| | |${(0.901)}$| |
95% CI | |$[ -0.04, 0.21]$| | |$[ -0.04, 0.19]$| |
Base controls | X | X |
Health controls | X | |
Observations | 5,773 | 5,773 |
. | (1) . | (2) . |
---|---|---|
Panel A: Insulin usage 2000 vs. 2006 . | . | |
IMSS |$\times$| 2006 | 0.009 | 0.009 |
p-value | |${(0.709)}$| | |${(0.739)}$| |
95% CI | |$[ -0.16, 0.03]$| | |$[ -0.14, 0.04]$| |
Base controls | X | X |
Health controls | X | |
Observations | 4,145 | 4,145 |
(3) | (4) | |
Panel B: Other treatment | ||
DiD coeff. | |$-0.004$| | |$-0.004$| |
p-value | |${(0.898)}$| | |${(0.901)}$| |
95% CI | |$[ -0.04, 0.21]$| | |$[ -0.04, 0.19]$| |
Base controls | X | X |
Health controls | X | |
Observations | 5,773 | 5,773 |
Notes: Difference-in-differences coefficients for placebo tests on insulin utilization (Panel A) and adherence to nutrition plans (Panel B). For control definitions, see Table 4. Wild cluster bootstrap p-values and confidence intervals are reported below each coefficient.
. | (1) . | (2) . |
---|---|---|
Panel A: Insulin usage 2000 vs. 2006 . | . | |
IMSS |$\times$| 2006 | 0.009 | 0.009 |
p-value | |${(0.709)}$| | |${(0.739)}$| |
95% CI | |$[ -0.16, 0.03]$| | |$[ -0.14, 0.04]$| |
Base controls | X | X |
Health controls | X | |
Observations | 4,145 | 4,145 |
(3) | (4) | |
Panel B: Other treatment | ||
DiD coeff. | |$-0.004$| | |$-0.004$| |
p-value | |${(0.898)}$| | |${(0.901)}$| |
95% CI | |$[ -0.04, 0.21]$| | |$[ -0.04, 0.19]$| |
Base controls | X | X |
Health controls | X | |
Observations | 5,773 | 5,773 |
. | (1) . | (2) . |
---|---|---|
Panel A: Insulin usage 2000 vs. 2006 . | . | |
IMSS |$\times$| 2006 | 0.009 | 0.009 |
p-value | |${(0.709)}$| | |${(0.739)}$| |
95% CI | |$[ -0.16, 0.03]$| | |$[ -0.14, 0.04]$| |
Base controls | X | X |
Health controls | X | |
Observations | 4,145 | 4,145 |
(3) | (4) | |
Panel B: Other treatment | ||
DiD coeff. | |$-0.004$| | |$-0.004$| |
p-value | |${(0.898)}$| | |${(0.901)}$| |
95% CI | |$[ -0.04, 0.21]$| | |$[ -0.04, 0.19]$| |
Base controls | X | X |
Health controls | X | |
Observations | 5,773 | 5,773 |
Notes: Difference-in-differences coefficients for placebo tests on insulin utilization (Panel A) and adherence to nutrition plans (Panel B). For control definitions, see Table 4. Wild cluster bootstrap p-values and confidence intervals are reported below each coefficient.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.